Enzolytics Inc (ENZC)

[Timing101]

ENZC
---
When you are real , it takes a little time . That LOI is between parties like Harry Z with his patents and the Bioclonetics Super Bowl Team that agree on things professionally and Legally and have already let their INTENT be known .
--
Harry Z patents all medical and inventive Procedures .
https://patents.google.com/?inventor=Harry+H.+Zhabilov
--
Charles C .. Attorney for over 40 years and Joe C , Dr and Speaker at major conferences... plus the rest of their team .
http://bioclonetics.com/who-we-are.html
--
Then Harry files an 8-k to let all know ENZC is now operating out of Plano Texas ... right next door to the BioClonetics Team.
https://www.otcmarkets.com/filing/html?id=14076248&guid=awI6U65Tb1ur_3h
--
Oh yes this is happening , by the way did you happen to NOTICE where the Bioclonetics PR came from on Final Stages.. PLANO TEXAS.
it is easy to Merge when you are in the same City and development
area .. Major TEXAS Funding in Medical Research.
Read the Last paragraph
https://www.bizjournals.com/dallas/inno/stories/news/2020/09/18/eyevance-pharmaceuticals-jerry-st-peter.html
--
and Final Stages of testing at the ReKnown University of DAVIS , the University HQ for final testing's and approvals.
*
https://www.biospace.com/article/releases/-enzolytics-mergers-and-acquisitions/
*
Quote
"Published: Sep 16, 2020

PLANO, TX / ACCESSWIRE / September 16, 2020 / Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the execution of a non-binding letter of intent (the "LOI") to merge with BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas.

BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested. [http://www.bioclonetics.com/validation.html]. Final testing of BioClonetics' anti-HIV recombinant mAbs in PBMC neutralization assays are being conducted to be followed by animal trials at the California National Primate Research Center, UCDavis (Davis, CA).